BioWorld Asia

Sep. 27, 2006

Merck KGaA Buying Serono, Giving CHF16.6B Valuation

Merck KGaA agreed to acquire a controlling stake in Serono SA by purchasing the Bertarelli family's shares in the company, which represent 64.5 percent of its equity and 75.5 percent of its voting rights. (BioWorld International) Read More

GPC Biotech Shares Jump On Prostate Cancer Study Results

Proteomics Approach Could Bring Rapid Dipstick For TB

Another European Agenda For Innovative Medicines

Jerini Shares Plummet On Mixed Phase III Trial News

India's Avesthagen Seeking VC Money, Eyeing 2008 IPO

BioAlliance Pharma Reports Phase I/II Doxorubicin Data

Europe Trails U.S. In Tech Transfer; Patents Lag, Too

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 29, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Investors bet on transformative BCI tech for neuro disorders

BioWorld

An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....

BIO 2026: Alternatives to funding orphan drugs

BioWorld

At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...

Illustration demonstrating gut-brain axis

CINP 2026: Gut microbiota could predict antidepressant response

BioWorld

The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...